|Articles|April 15, 2016
- Gastrointestinal Special Issue
- Volume 1
- Issue 1
Medical Illustration: Targeting HER2 in Gastric Cancer
Author(s)Erin Moore
For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
Advertisement
ILLUSTRATION BY ERIN MOORE
ORIGINALLY PUBLISHED IN “GUT REACTION,” CURE WINTER 2009
*HER2 is also associated with breast cancer.
For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
Articles in this issue
over 9 years ago
An Insight Into Gastric Cancers and Life Without a Stomachover 9 years ago
Changing Lives With ImmunotherapyAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Sacituzumab Tirumotecan Improves Survival in EGFR-Mutated Non-Small Cell Lung Cancer
2
Facing Mortality After Cancer, and Choosing to Live Fully
3
Tecentriq Plus Chemo Shows Comparable Survival in Endometrial Cancer
4
Imfinzi Combo Improves Progression Free Survival in Ovarian Cancer
5
